Shiqin (Laura) Liu, MD, PhD

Shiqin (Laura) Liu, MD, PhD

Assistant Adjunct Professor, Department of Molecular and Medical Pharmacology

Languages

English

Education

Fellowships

Cancer Biology, Stanford University, Stanford, CA, 2022
Pharmacology, University of California, Los Angeles, CA, 2024

Degrees

PhD, Peking University, Beijing, China, 2017
Joint PhD, University of Miami, Coral Gables, FL, 2016

Residency

Surgery, Central South University, Changsha, China, 2017

Contact Information

Scientific Interests

Dr. Liu's research interests are identifying new molecular mechanisms underlying cancer development, improving cancer early detection, and discovering molecular-based therapeutic strategies for clinically significant diseases.

Highlighted Publications

Liu S, Chai T, Garcia-Marques F, Yin Q, Hsu EC, Shen M, Shaw Toland AM, Bermudez A, Hartono AB, Massey CF, Lee CS, Zheng L, Baron M, Denning CJ, Aslan M, Nguyen HM, Nolley R, Zoubeidi A, Das M, Kunder CA, Howitt BE, Soh HT, Weissman IL, Liss MA, Chin AI, Brooks JD, Corey E, Pitteri SJ, Huang J, Stoyanova T. UCHL1 is a potential molecular indic tor and therapeutic target for neuroendocrine carcinomas. Cell Rep Med. 2024 Feb 20; 5(2):101381.

Guimarães, C+, Liu, S+., Wang, J+., Purcell, E., Ozedirne, T., Ren, T., Aslan, M., Yin, Q., Reis, R., Stoyanova, T., *, Demirci, U*., Co-axial Hydrogel Spinning for Facile Biofabrication of Prostate Cancer-like 3D Models. Biofabrication. 2024 02 20; 16(2). +Those authors contribute equally.

Liu, S+., Hawley, S+., Kunder, C., Hsu, E., Shen, M., Westphalen L., Auman, H, Lisa F., Lin, D., Nelson, P., Feng, Z., Tretiakova, M., True, L., Vakar-Lopez, F., Carroll, P., Simko, J., Gleave, M., Troyer, D., McKenney, J., Brooks, J., Liss, M.*, and Stoyanova, T*. High Expression of Trop2 Is Associated with Aggressive Localized Prostate Cancer and is a Candidate Urinary Biomarker. Sci Rep. 2024 01 04; 14(1):486. +Those authors contribute equally.

Liu, S., Lee, J, Marques, F J, Nolley, R, Shen, M, Hsu, E C, Aslan, M, Pitteri, S J, Brooks, J D, Stoyanova, T*. Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay. Sci Rep. 2021 Apr 7;11(1):7612.

Liu, S., Shen, M., Hsu, E. C., Zhang, C. A., Marques, F. J., Nolley, R., Koul, K., Rice, M. A., Aslan, M., Pitteri, S J., Brooks, J D., Massie, C., George, A., Gnanapragasam, V J*., Stoyanova, T*. Discovery of PTN as a blood-based biomarker of pro-metastatic prostate cancer. Br J Cancer, 2021 Mar;124(5):896-900.